0001415889-20-003039.txt : 20201228
0001415889-20-003039.hdr.sgml : 20201228
20201228195732
ACCESSION NUMBER: 0001415889-20-003039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201223
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Travia Richard C.
CENTRAL INDEX KEY: 0001830896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54457
FILM NUMBER: 201419790
MAIL ADDRESS:
STREET 1: 6565 E. EVANS AVENUE
CITY: DENVER
STATE: CO
ZIP: 80224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENERAL CANNABIS CORP
CENTRAL INDEX KEY: 0001477009
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-DETECTIVE, GUARD & ARMORED CAR SERVICES [7381]
IRS NUMBER: 208096131
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6565 EAST EVANS AVENUE
CITY: DENVER
STATE: CO
ZIP: 80224
BUSINESS PHONE: 303-759-1300
MAIL ADDRESS:
STREET 1: 6565 EAST EVANS AVENUE
CITY: DENVER
STATE: CO
ZIP: 80224
FORMER COMPANY:
FORMER CONFORMED NAME: Advanced Cannabis Solutions, Inc.
DATE OF NAME CHANGE: 20131023
FORMER COMPANY:
FORMER CONFORMED NAME: Promap Corp
DATE OF NAME CHANGE: 20091117
4
1
form4-12282020_041219.xml
X0306
4
2020-12-23
0001477009
GENERAL CANNABIS CORP
CANN
0001830896
Travia Richard C.
C/O GENERAL CANNABIS CORP.
6565 EAST EVANS AVENUE
DENVER
CO
80224
true
false
false
false
Senior Convertible Promissory Note
0.65
2020-12-23
4
P
0
76923
A
2020-12-23
2023-12-23
Common stock
76923
76923
D
Warrants
0.56
2020-12-23
4
P
0
35715
A
2020-12-23
2025-12-23
Common stock
35715
35715
D
Pursuant to a Securities Purchase Agreement ("SPA") entered into on December 23, 2020 by the Reporting Person and the Issuer, each Senior Convertible Promissory Note (the "Note") accrues interest at a rate of 10% per annum. The Reporting Person purchased a Note in the principal amount of $100,000 and has the option to convert up to 50% of the outstanding unpaid principal and accrued interest of the Note into the Issuer's Common Stock at a variable price of 80% of the market price but no less than $0.65 per share and no more than $1.00 per share.
In connection with the SPA, the Reporting Person also received Warrants to purchase the number of shares of the Issuer's Common Stock equal to 20% of the principal amount of the Note divided by the exercise price of $0.56.
/s/ Richard C Travia
2020-12-28